For: | Xie X, Wang CY, Cao YX, Wang W, Zhuang R, Chen LH, Dang NN, Fang L, Jin BQ. Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissues. World J Gastroenterol 2005; 11(3): 344-347 [PMID: 15637741 DOI: 10.3748/wjg.v11.i3.344] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i3/344.htm |
Number | Citing Articles |
1 |
Jacqueline F. Morris, Jai-Yoon Sul, Min-Sun Kim, Andres J. Klein-Szanto, Terri Schochet, Anil Rustgi, James H. Eberwine. Elk-1 phosphorylated at threonine-417 is present in diverse cancers and correlates with differentiation grade of colonic adenocarcinoma. Human Pathology 2013; 44(5): 766 doi: 10.1016/j.humpath.2012.08.001
|
2 |
Junhong Chen, Xiaoyan Zhuang, Jiyang Zheng, Ruofan Yang, Fei Wu, Aihui Zhang, Baishan Fang. Aptamer-based cell-free detection system to detect target protein. Synthetic and Systems Biotechnology 2021; 6(3): 209 doi: 10.1016/j.synbio.2021.07.004
|
3 |
E. M. V. de Cuba, R. Kwakman, M. van Egmond, L. J. W. Bosch, H. J. Bonjer, G. A. Meijer, E. A. te Velde. Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer. Virchows Archiv 2012; 461(3): 231 doi: 10.1007/s00428-012-1287-y
|
4 |
Seok Joo Lee, Kee Yang Chung, Ji Eun Kwon, Sun Och Yoon, Sang Kyum Kim. Expression of EpCAM in adenoid cystic carcinoma. Pathology 2018; 50(7): 737 doi: 10.1016/j.pathol.2018.08.013
|
5 |
Thais Peretti, Jaques Waisberg, Ana Maria A. A. Mader, Leandro L. de Matos, Ricardo B. da Costa, Gleice Margarete de S. Conceição, Antônio Carlos Lopes, Helena B. Nader, Maria Aparecida S. Pinhal. Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma. European Journal of Gastroenterology & Hepatology 2008; 20(8): 756 doi: 10.1097/MEG.0b013e3282fc2649
|
6 |
Yang Zhou, Jun-Ting Cheng, Zi-Xian Feng, Ying-Ying Wang, Ying Zhang, Wen-Qi Cai, Zi-Wen Han, Xian-Wang Wang, Ying Xiang, Hui-Yu Yang, Bing-Rong Liu, Xiao-Chun Peng, Shu-Zhong Cui, Hong-Wu Xin. Could gastrointestinal tumor-initiating cells originate from cell-cell fusion <i>in vivo</i>?. World Journal of Gastrointestinal Oncology 2021; 13(2): 92-108 doi: 10.4251/wjgo.v13.i2.92
|
7 |
Marleen van Oosten, Lucia M.A. Crane, Joost Bart, Fijs W. van Leeuwen, Gooitzen M. van Dam. Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. Translational Oncology 2011; 4(2): 71 doi: 10.1593/tlo.10220
|
8 |
Monika Trzpis, Pamela M.J. McLaughlin, Lou M.F.H. de Leij, Martin C. Harmsen. Epithelial Cell Adhesion Molecule. The American Journal of Pathology 2007; 171(2): 386 doi: 10.2353/ajpath.2007.070152
|
9 |
Yanfang Si, Jun Wang, Juan Guan, Quanhong Han, Yannian Hui. Platelet-Derived Growth Factor Induced Alpha-Smooth Muscle Actin Expression by Human Retinal Pigment Epithelium Cell. Journal of Ocular Pharmacology and Therapeutics 2013; 29(3): 310 doi: 10.1089/jop.2012.0137
|
10 |
Hannah Woopen, Klaus Pietzner, Rolf Richter, Christina Fotopoulou, Thomas Joens, Elena Ioana Braicu, Håkan Mellstedt, Sven Mahner, Horst Lindhofer, Silvia Darb-Esfahani, Carsten Denkert, Jalid Sehouli. Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer. Journal of Gynecologic Oncology 2014; 25(3): 221 doi: 10.3802/jgo.2014.25.3.221
|
11 |
Ioanna Kalaitsidou, Nikoleta Pasteli, Gregory Venetis, Athanasios Poulopoulos, Konstantinos Antoniades. Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Salivary Gland Cancer: Correlation with the Biological Behavior. Diagnostics 2023; 13(16): 2652 doi: 10.3390/diagnostics13162652
|
12 |
Manal Amoury, Katharina Kolberg, Anh-Tuan Pham, Dmitrij Hristodorov, Radoslav Mladenov, Stefano Di Fiore, Wijnand Helfrich, Fabian Kiessling, Rainer Fischer, Alessa Pardo, Theophilus Thepen, Ahmad F. Hussain, Thomas Nachreiner, Stefan Barth. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Cancer Letters 2016; 372(2): 201 doi: 10.1016/j.canlet.2016.01.027
|
13 |
Laurent Dollé, Neil D. Theise, Eva Schmelzer, Luke Boulter, Olivier Gires, Leo A. van Grunsven. EpCAM and the biology of hepatic stem/progenitor cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(4): G233 doi: 10.1152/ajpgi.00069.2014
|
14 |
Y. S. Kim, A. M. Kaidina, J.-H. Chiang, K. N. Yarygin, A. Yu. Lupatov. Cancer stem cell molecular markers verified in vivo. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2017; 11(1): 43 doi: 10.1134/S1990750817010036
|
15 |
Y.S. Kim, A.M. Kaidina, J.H. Chiang, K.N. Yarygin, A.Yu. Lupatov. Molecular markers of cancer stem cells verified in vivo. Biomeditsinskaya Khimiya 2016; 62(3): 228 doi: 10.18097/PBMC20166203228
|
16 |
Devilakshmi Sithambaram, Shanthi Palanivelu, Krishnakumar Subramanian, Sanjeeb Sahoo, Rama S. Verma. Specific Targeting of Ep-CAM in Various Carcinomas by Novel Monoclonal Antibodies. Hybridoma 2011; 30(6): 511 doi: 10.1089/hyb.2011.0069
|
17 |
Du Wenqi, Wang Li, Cao Shanshan, Chen Bei, Zhang Yafei, Bai Feihu, Liu Jie, Fan Daiming. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer. Journal of Cancer Research and Clinical Oncology 2009; 135(9): 1277 doi: 10.1007/s00432-009-0569-5
|
18 |
Wenjuan Tang, Taosheng Huang, Zhongyao Xu, Ying Huang. Novel Mutations in EPCAM Cause Congenital Tufting Enteropathy. Journal of Clinical Gastroenterology 2018; 52(1): e1 doi: 10.1097/MCG.0000000000000739
|
19 |
Xin Xie, Zhenjie Xu, Jihong Cui, Boquan Jin. A Non-Stimulatory Monoclonal Antibody Against the Inhibitory Immunoreceptor LAIR-1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2014; 33(2): 141 doi: 10.1089/mab.2013.0062
|
20 |
Minghua Lv, Feng Qiu, Tingting Li, Yuanjie Sun, Chunmei Zhang, Ping Zhu, Xiaokun Qi, Jun Wan, Kun Yang, Kui Zhang, Lijun Xin. Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/460264
|
21 |
Arjune Premsukh, Joelle M. Lavoie, Jeannick Cizeau, Joycelyn Entwistle, Glen C. MacDonald. Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation. Protein Expression and Purification 2011; 78(1): 27 doi: 10.1016/j.pep.2011.03.009
|
22 |
Joycelyn Entwistle, Mark Kowalski, Jennifer Brown, Jeannick Cizeau, Glen C. MacDonald. Antibody-Drug Conjugates and Immunotoxins. 2013; : 349 doi: 10.1007/978-1-4614-5456-4_19
|
23 |
Julie Salomon, Yolanda Espinosa-Parrilla, Olivier Goulet, Wafa’a Al-Qabandi, Philippe Guigue, Danielle Canioni, Julie Bruneau, Fatema Alzahrani, Saleh Almuhsen, Nadine Cerf-Bensussan, Marc Jeanpierre, Nicole Brousse, Stanislas Lyonnet, Arnold Munnich, Asma Smahi. A founder effect at the EPCAM locus in Congenital Tufting Enteropathy in the Arabic Gulf. European Journal of Medical Genetics 2011; 54(3): 319 doi: 10.1016/j.ejmg.2011.01.009
|
24 |
Kun-he Zhang, Feng Cao, Qu-bo Fu, Jin-quan Zhu, Jiang Chen, Nong-hua Lv. Detection of mRNAs of GA733 Genes by RT-PCR in Exfoliated Cells of Pleural and Peritoneal Effusions and Its Clinical Values. Internal Medicine 2007; 46(18): 1489 doi: 10.2169/internalmedicine.46.0199
|
25 |
Joycelyn Entwistle, Jennifer G. Brown, Shilpa Chooniedass, Jeannick Cizeau, Glen C. MacDonald. Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential. Cancer Biotherapy and Radiopharmaceuticals 2012; 27(9): 582 doi: 10.1089/cbr.2012.1200.271
|
26 |
Dmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, Judith Niesen, Katharina Arens, Nina Berges, Lea Hein, Stefano Di Fiore, Anh-Tuan Pham, Michael Huhn, Wijnand Helfrich, Rainer Fischer, Theo Thepen, Stefan Barth. EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein. Molecular Cancer Therapeutics 2014; 13(9): 2194 doi: 10.1158/1535-7163.MCT-13-0781
|
27 |
Yong Zhang, WenYong Wang, ZhiJian Sun, DongYun Feng, YanChun Deng, YongHong Liu, Gang Zhao, HuaNing Wang, YuanGui Huang. Granulocyte Colony-Stimulating Factor Treatment Prevents Cognitive Impairment Following Status Epilepticus in Rats. Biological & Pharmaceutical Bulletin 2010; 33(4): 572 doi: 10.1248/bpb.33.572
|
28 |
Diyuan Qin, Dan Li, Benxia Zhang, Yue Chen, Xuelian Liao, Xiaoyu Li, Peter B. Alexander, Yongsheng Wang, Qi-Jing Li. Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models. OncoImmunology 2020; 9(1) doi: 10.1080/2162402X.2020.1806009
|
29 |
Kazuhiro Suzuki, Kiminori Nakamura, Kazunori Kato, Hirofumi Hamada, Taiji Tsukamoto. Exploration of target molecules for prostate cancer gene therapy. The Prostate 2007; 67(11): 1163 doi: 10.1002/pros.20613
|
30 |
Judith E.K.R. Hentzen, Steven J. de Jongh, Patrick H.J. Hemmer, Willemijn Y. van der Plas, Gooitzen M. van Dam, Schelto Kruijff. Molecular fluorescence‐guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review. Journal of Surgical Oncology 2018; 118(2): 332 doi: 10.1002/jso.25106
|
31 |
Jeannick Cizeau, Danielle M. Grenkow, Jennifer G. Brown, Joycelyn Entwistle, Glen C. MacDonald. Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin. Journal of Immunotherapy 2009; 32(6): 574 doi: 10.1097/CJI.0b013e3181a6981c
|
32 |
Goran Benko, Borislav Spajić, Božo Krušlin, Davor Tomas. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer. Urologic Oncology: Seminars and Original Investigations 2013; 31(4): 468 doi: 10.1016/j.urolonc.2011.03.007
|
33 |
Wenqi Du, Hongzan Ji, Shanshan Cao, Li Wang, Feihu Bai, Jie Liu, Daiming Fan. RETRACTED ARTICLE: EpCAM: A Potential Antimetastatic Target for Gastric Cancer. Digestive Diseases and Sciences 2010; 55(8): 2165 doi: 10.1007/s10620-009-1033-8
|